TA
IONS icon

Teachers Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Teachers Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$15.5M Buy
191,384
+39,198
+26% +$2.53M 0.02% 773
2018
Q4 		$8.23M Sell
152,186
-3,405
-2% -$174K 0.01% 1034
2018
Q3 		$8.03M Buy
155,591
+18,178
+13% +$854K 0.01% 1177
2018
Q2 		$5.73M Buy
137,413
+346
+0.3% +$15.3K 0.01% 1353
2018
Q1 		$6.04M Buy
137,067
+3,060
+2% +$155K 0.01% 1242
2017
Q4 		$6.74M Buy
134,007
+1,913
+1% +$105K 0.01% 1207
2017
Q3 		$6.7M Sell
132,094
-18,562
-12% -$972K 0.01% 1192
2017
Q2 		$7.66M Buy
150,656
+19,000
+14% +$885K 0.01% 1121
2017
Q1 		$5.29M Buy
131,656
+7,846
+6% +$352K 0.01% 1272
2016
Q4 		$5.92M Buy
123,810
+15,904
+15% +$629K 0.01% 1193
2016
Q3 		$3.95M Sell
107,906
-13,298
-11% -$416K 0.01% 1340
2016
Q2 		$2.82M Buy
121,204
+7,477
+7% +$241K ﹤0.01% 1457
2016
Q1 		$4.61M Buy
113,727
+3,097
+3% +$126K 0.01% 1168
2015
Q4 		$6.85M Buy
110,630
+958
+0.9% +$51.7K 0.01% 1027
2015
Q3 		$4.43M Sell
109,672
-184,458
-63% -$9.55M 0.01% 1166
2015
Q2 		$16.9M Sell
294,130
-103,734
-26% -$6.6M 0.03% 636
2015
Q1 		$25.3M Sell
397,864
-69,704
-15% -$4.73M 0.05% 491
2014
Q4 		$28.9M Buy
467,568
+272
+0.1% +$13.4K 0.06% 433
2014
Q3 		$18.1M Buy
467,296
+13,540
+3% +$480K 0.04% 581
2014
Q2 		$15.6M Buy
453,756
+163,012
+56% +$5.13M 0.03% 675
2014
Q1 		$12.6M Buy
290,744
+67,250
+30% +$3.26M 0.03% 742
2013
Q4 		$8.9M Buy
223,494
+67,320
+43% +$2.4M 0.02% 866
2013
Q3 		$5.86M Buy
156,174
+7,065
+5% +$211K 0.01% 977
2013
Q2 		$4.01M Buy
+149,109
New +$3.17M 0.01% 1086

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's IONS Position: Q1 2019 in Review

Teachers Advisors increased its Ionis Pharmaceuticals (IONS) stake by 26% in Q1 2019, buying an estimated $2.53M and bringing the position to 191,384 shares worth $15.5M. The position accounts for 0.02% of the portfolio, ranked #773.

Teachers Advisors first reported a position in IONS in Q2 2013 and has held it in 24 quarters since. The position peaked at $28.9M in Q4 2014. 392 funds tracked by Wall St. Rank hold IONS as of Q1 2019.

  • Teachers Advisors held 191,384 shares of Ionis Pharmaceuticals worth $15.5M as of Q1 2019.
  • Teachers Advisors bought 39,198 Ionis Pharmaceuticals shares in Q1 2019, an estimated $2.53M.
  • Ionis Pharmaceuticals made up 0.02% of Teachers Advisors's portfolio in Q1 2019, its #773 holding.
  • Teachers Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Ionis Pharmaceuticals position peaked at $28.9M in Q4 2014.
  • 392 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.